The Benefit of ADT Treatment Intensification with Radiotherapy for Men with Localized Prostate Cancer, Journal Club – Christopher Wallis & Zachary Klaassen

Christopher Wallis and Zachary Klaassen discuss MARCAP, a meta-analysis of randomized trials in cancer of the prostate. This individual patient data meta-analysis of relevant randomized trials aimed to quantify the benefit of various androgen deprivation therapy (ADT) intensification strategies in men receiving radiotherapy for the treatment of prostate cancer in aggregate and in clinically…

Read the full article here

Source: UroToday

Categories: General Medicine News, Latest Headlines

Tags: JournalClub, ProstateCancer

Tweets with this article

UroToday.com

The benefit of ADT treatment intensification with radiotherapy for men with localized #ProstateCancer. @WallisCJD & @zklaassen_md discuss MARCAP, a meta-analysis of randomized trials in cancer of the prostate in this #JournalClub discussion on UroToday > https://t.co/HdhO8oZroI https://t.co/71hvmAAsho

Patient-Specific Targeted Analysis of Circulating Tumour DNA in Plasma Is Feasible and May Be a Potential Biomarker in Upper Tract Urothelial Cancer – Beyond the Abstract

Upper Tract Urothelial Cancer (UTUC), Circulating tumor DNA (ctDNA), Circulating Tumour DNA in Plasma Is Feasible and May Be a Potential Biomarker, detection of tumor-specific…

UroToday.com May 8, 2024

Can Simplified PADUA Renal (SPARE) Nephrometry Scoring System Help Predict Renal Function Outcomes after Robot-Assisted Partial Nephrectomy? (UroCCR Study 93) – Beyond the Abstract

PADUA Renal (SPARE) Nephrometry Scoring System, Renal Function Outcomes After Robot-Assisted Partial Nephrectomy, Robot-Assisted Partial Nephrectomy, UroCCR Study 93, Chronic Kidney Disease (CKD), RAPN for…

UroToday.com May 8, 2024

Active Surveillance Should Not Be Routinely Considered in ISUP Grade Group 2 Prostate Cancer – Beyond the Abstract

prostate cancer, grade group 2 prostate cancer, ProtecT trial, International Society of Urological Pathologists (ISUP), ISUP grading system, radical prostatectomy, low-grade prostate cancer.

UroToday.com May 8, 2024

PSMA-Targeted Radionuclide Therapy in the Pre- and Post-Chemotherapy Settings in Prostate Cancer – Louise Emmett

In a conversation with Phillip Koo, Louise Emmett unpacks the complexities of PSMA-targeted diagnostics and treatments in prostate cancer. They explore the significance of key…

UroToday.com May 8, 2024

PSMA PET & The Impact of the PRIMARY Trial “Presentation” – Louise Emmett

At the 2024 PSMA Conference PSMA PET and RLT: Present and Future, Louise Emmett explores enhancing prostate cancer diagnosis with PSMA PET imaging, revealing the…

UroToday.com May 8, 2024

Testicular Radiomics To Predict Pathology At Time of Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Tumor – Beyond the Abstract

testicular cancer, Testicular germ cell tumors (TGCTs), non-seminomatous germ cell tumors (NSGCTs), retroperitoneal lymph node dissection (RPLND), non-seminomatous germ cell tumors after chemotherapy.

UroToday.com May 8, 2024

An Analysis in NMIBC Patients – A Comparative Study of White Light and Blue Light Cystoscopy in an Equal Access Setting – Stephen B. Williams

Stephen Williams discusses the evolving role of blue light cystoscopy in detecting non-muscle invasive bladder cancer (NMIBC). The conversation covers its pathophysiology, diagnostic and surveillance…

UroToday.com May 8, 2024

Case-Based Discussion on Navigating the Evolving Landscape of Castrate-Resistant Prostate Cancer Management – Oliver Sartor

Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: A.…

UroToday.com May 8, 2024

Radioligand Therapy’s Role in Treating mCRPC – Oliver Sartor

Alicia Morgans engages in a conversation with Oliver Sartor about the evolving landscape of Radioligand Therapy in metastatic castration-resistant prostate cancer (mCRPC). Dr. Sartor discusses…

UroToday.com May 8, 2024

Patient Selection for PSMA Radioligand Therapy – Ephraim Parent

Phillip Koo engages in a conversation with Ephraim Parent on the pivotal role of PSMA PET imaging in selecting patients for radioligand therapy (RLT). Dr.…

UroToday.com May 8, 2024

Related Articles